Federal Reports

To see our report, click on the link below

Summaries of employee integrity investigation cases closed during the semiannual reporting period noted.

The Office of Inspector General (OIG) evaluated NASA's implementation of the recommendations made by the OIG, Government Accountability Office, and National Academy of Public Administration to improve NASA's export-control and foreign national access programs.

The objective of this audit was to determine NARA's compliance with improper payment requirements based on Office of Management and Budget Memorandum 15-02 and OMB Circular A-136.

The Utah Department of Health, Division of Medicaid and Health Financing (State agency), did not always comply with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs. The State agency did not invoice manufacturers for rebates associated with $6,188,000 ($4,387,000 Federal share) in physician-administered drugs. Of this amount, $5,189,000 ($3,679,000 Federal share) was for single-source drugs, and $999,000 ($709,000 Federal share) was for top-20 multiple-source drugs. Because the State agency's internal controls did not always ensure that it invoiced manufacturers to secure rebates, the State agency improperly claimed Federal reimbursement for these single-source drugs and top-20 multiple-source drugs.